Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Strategy& Insider Episode 18 - Pursuing the next big thing in big pharma

Strategy& Insider Episode 18 - Pursuing the next big thing in big pharma

FromStrategy& Insider


Strategy& Insider Episode 18 - Pursuing the next big thing in big pharma

FromStrategy& Insider

ratings:
Length:
39 minutes
Released:
Sep 30, 2022
Format:
Podcast episode

Description

In this episode, it instantly becomes clear why it is a privilege to help humankind by reaping cutting-edge science and technology for Dr. Christian Rommel. As the Head of R&D and member of the executive board at Bayer Pharmaceuticals, he shares his experience in transforming how we are developing and regulating drugs, his view on the key to future medical innovation, and addresses how to enable patients to benefit from such innovations.
Released:
Sep 30, 2022
Format:
Podcast episode

Titles in the series (24)

The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible. Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.